Appointment New Patient Appointment or 214-645-8300

Appointment New Patient Appointment or 214-645-8300

MedBlog

Search Results

MedBlog Search

Results: Articles

PARP-1 inhibitors can reduce ovarian cancer recurrence risk by 70% in half of patients

Cancer; Women's Health

PARP-1 inhibitors can reduce ovarian cancer recurrence risk by 70% in half of patients

PARP-1 inhibitor drugs can reduce the risk of BRCA- and HRDS-associated ovarian cancer by 70%. New research at UT Southwestern Medical Center may help expand treatment to more patients.

  • Jayanthi Lea, M.D.

September 16, 2021

Britni’s story: Destroying cancer, preserving fertility

Cancer

Britni’s story: Destroying cancer, preserving fertility

Dr. Richardson and her patient, Britni Adams, discuss radical trachelectomy, a procedure to treat cervical cancer and preserve fertility.

November 16, 2016